loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 206494 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 AVIBACTAM SODIUM; CEFTAZIDIME (1)

filter

01 ALLERGAN (1)

filter

01 POWDER;INTRAVENOUS (1)

filter

01 EQ 0.5GM BASE;2GM/VIAL (1)

filter

01 USA (1)

URL Supplier Web Content
POWDER;INTRAVENOUS
EQ 0.5GM BASE;2GM/VIAL
AVYCAZ
USA
206494
2015-02-25
RX
Abbvie CB

ICRI Spring Convention

Not Confirmed

envelop Contact Supplier

Looking for CTD TGA MCC DOSSIER APPLICATION 206494

Looking for CTD TGA MCC DOSSIER APPLICATION 206494 1

19

Allergan Aesthetics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is AVIBACTAM SODIUM; CEFTAZIDIME, with a corresponding application number 206494 and regulatory information .

proudly manufactured in the

approval since 2015-02-25

Allergan Aesthetics's AVYCAZ POWDER;INTRAVENOUS, medication with EQ 0.5GM BASE;2GM/VIAL of AVIBACTAM SODIUM; CEFTAZIDIME.

Post Enquiry
POST ENQUIRY